Leveraging Synthetic Lethality to Treat Cancer

February 20–23, 2020

Chaired by:
 Carla Grandori, MD, PhD of SEngine Precision Medicine
 Christopher Kemp, PhD of Fred Hutchinson

 Sponsored by The 2019 Holiday Matching Program

  No Summary Available

Cancer and Aging

November 7–10, 2019

Chaired by:
 Steve Artandi, MD, PhD of Stanford University
 Marcia Haigis, PhD of Harvard Medical School

 Sponsored by The George T. Lewis Foundation

  No Summary Available

Telomerase-Mediated Telomere Targeting in Cancer

October 17–20, 2019

Chaired by:
 Titia de Lange, PhD of Rockefeller University
 Jerry W. Shay, PhD of UT Southwestern

  Summary Available

Scholar Retreat

October 10–13, 2019

Chaired by:
 Chad Pecot, MD of University of North Carolina

  Summary Available

Diffuse Intrinsic Pontine Glioma

October 3–6, 2019

Chaired by:
 Oren Becher, MD of Northwestern University
 Cynthia Hawkins MD, PhD of The Hospital for Sick Kids

 Sponsored by The Kira Spedale Foundation

  Summary Available

Leukemia Stem Cells, Heterogeneity, and Metabolism

September 12–15, 2019

Chaired by:
 Martin Carroll, MD of University of Pennsyilvania
 Craig T. Jordan, PhD of University of Colorado
 Aaron Schimmer, MD, PhD of Princess Margaret Cancer Centre

  Summary Available

3D Chromosomal Architecture and Nuclear Topology

May 2–5, 2019

Chaired by:
 Ari Melnick, MD of Cornell Medical College
 Jane Skok, PhD of New York University

  Summary Available

Cancer Predisposition

November 8–11, 2018

Chaired by:
 Judy E. Garber, MD, MPH of Harvard University
 John M. Maris, MD of University of Pennsylvania

  No Summary Available

Tumor Microenvironment

November 1–4, 2018

Chaired by:
 Lisa M. Coussens, PhD of Knight Cancer Institute
 Rakesh K. Jain, PhD of Massachusetts General Hospital

  No Summary Available

Scholar Retreat

October 11–14, 2018

Chaired by:
 Julie-Aurore Losman, MD, PhD of Dana-Farber Cancer Institute

  Summary Available

Epigenetic Therapy

September 27–30, 2018

Chaired by:
 Jean-Pierre Issa, MD of Temple University
 Stephen Baylin, MD of Johns Hopkins University
 Peter Jones, PhD of Van Andel Research Institute

  Summary Available

Metabolic Signaling and the Epigenome

September 13–15, 2018

Chaired by:
 Julie-Aurore Losman, MD, PhD of Dana-Farber Cancer Institute
 Kathryn Wellen, PhD of University of Pennsylvania

  Summary Available

Convergence of Myc and Ras in Cancer

November 9–12, 2017

Chaired by:
 Karen Cichowski, PhD of Bringham and Women's Hospital and Harvard Medical School
 Gerard Evan PhD, FRS, FMedSci of University of Cambridge

  Summary Available

Scholar Retreat

October 12–15, 2017

Chaired by:
 Nabeel Bardeesy, PhD of Massachusetts General Hospital

  Summary Available

Precision Cancer Medicine by Functional Biomarkers

May 19–20, 2017

Chaired by:
 Anthony Letai MD, PhD of Dana-Farber Cancer Institute

  Summary Available

Chromosomal Instability and Aneuploidy

November 10–13, 2016

Chaired by:
 Angelika Amon, PhD of Massachusetts Institute of Technology
 David Pellman, MD, of Dana-Farber Cancer Institute

  Summary Available

Scholar Retreat

October 13–16, 2016

Chaired by:
 Kristina Cole, MD, PhD of Children's Hospital of Philadelphia

  No Summary Available

Renal Medullary Carcinoma

April 22–23, 2016

Chaired by:
 Kimryn Rathmell MD, PhD of Vanderbilt University
 Nizar Tannir MD of MD Anderson Cancer Center

  Summary Available

Cancer Immunotherapy

November 12–15, 2015

Chaired by:
 Catherine Bollard, MD of Washington Children’s Hospital
 Daniel Powell, PhD of University of Pennsylvania

  Summary Available

Scholar Retreat

October 1–4, 2015

Chaired by:
 Kimryn Rathmell, MD, PhD of Vanderbilt University

  Summary Available

Invasion & Metastasis

November 6–9, 2014

Chaired by:
 Ann Chambers, PhD of London Health Sciences Centre
 Zena Werb, PhD of University of California San Francisco

  Summary Available

Scholar Retreat

September 11–14, 2014

Chaired by:
 Clark C. Chen, MD, PhD of University of California San Diego

  Summary Available

Extracellular Vesicles: Promises and Pitfalls

April 12–13, 2014

Chaired by:
 Clark C. Chen, MD, PhD of University of California San Diego

  No Summary Available

Resistance Mechanisms

November 7–10, 2013

Chaired by:
 Joan Brugge, PhD of Harvard Medical School
 Jeffrey Engelman, MD, PhD of Massachusetts General Hospital

  Summary Available

Scholar Retreat

September 12–15, 2013

Chaired by:
 Carl D. Novina MD, PhD of Dana-Farber Cancer Institute

  Summary Available

Tumor Metabolism

November 1–4, 2012

Chaired by:
 Eileen White, PhD of The Cancer Institute of New Jersey
 Lewis C. Cantley, PhD of Weill Cornell Medical College

  Summary Available

Scholar Retreat

September 13–15, 2012

Chaired by:
 Anthony Letai MD, PhD of Dana-Farber Cancer Institute

  Summary Available

By Passing the Blood Brain Barriers to Improve Drug Delivery to Tumor in the Central Nervous System

February 23–26, 2012

Chaired by:
 Oren Becher, MD of Duke University
 Robert Wechsler-Reya, PhD of Sanford-Burnham Institute

  Summary Available

Epigenetics & Drug Therapy

November 3–7, 2011

Chaired by:
 Scott A. Armstrong, MD, PhD of Dana-Farber Cancer Institute
 Steven Henrikoff, PhD of Fred Hutchinson Cancer Research Center

  Summary Available

Scholar Retreat

September 15–18, 2011

Chaired by:
 Kimberly Kelly, PhD of Massachusetts General Hospital

  Summary Available

Childhood Germ Cell Tumors: Origins, Models & New Treatment Paradigms

March 5–7, 2011

Chaired by:
 James Amatruda, MD, PhD of UT Southwestern Medical Center
 Lindsay Frazier of Dana-Farber Cancer Institute

  Summary Available

Cancer Genomics

November 4–7, 2010

Chaired by:
 Richard Kolodner, PhD of University Of California, San Diego
 Michael R. Stratton, FRCPath of Sanger Institute

  Summary Available

Scholar Retreat

September 16–19, 2010

Chaired by:
 Norman Sharpless, MD of University of North Carolina

  Summary Available

The Biology And Treatment Of Primary Brain Tumors

November 5–8, 2009

Chaired by:
 Tracy Batchelor, MD, MPH of Harvard Medical School
 Andluis F. Parada, PhD of UT Southwestern

  Summary Available

Scholar Retreat

September 17–20, 2009

Chaired by:
 Jan Karlseder, PhD of The Salk Institute

  Summary Available

Immunotherapy And Breaking Tolerance

November 6–9, 2008

Chaired by:
 James P. Allison, PhD of Memorial Sloan Kettering Cancer Center
 Stanley Riddell, MD of Fred Hutchinson Cancer Research Center

  Summary Available

Scholar Retreat

September 11–14, 2008

Chaired by:
 David E. Fisher, MD, PhD of Dana-Farber Cancer Institute

  Summary Available

Micro RNA and Cancer

November 1–4, 2007

Chaired by:
 Carlo M. Croce, MD of The Ohio State University
 Gregory J. Hannon, PhD of Cold Spring Harbor Laboratory

  Summary Available

Scholar Retreat

September 13–16, 2007

Chaired by:
 Jan Karlseder, PhD of The Salk Institute

  Summary Available

Stem Cells

November 2–5, 2006

Chaired by:
 John E. Dick, PhD of University Of Toronto
 David Scadden, MD of Massachusetts General Hospital

  Summary Available

Scholar Retreat

September 14–17, 2006

Chaired by:
 Ed Harlow, PhD of Harvard Medical School

  Summary Available

Innovations in Imaging in Cancer Research

November 3–6, 2005

Chaired by:
 Harvey R. Herschman, PhD of UCLA
 Ralph Weissleder, MD, PhD of Massachusetts General Hospital

  Summary Available

Scholar Retreat

September 15–18, 2005

Chaired by:
 David E. Fisher, MD, PhD of Dana-Farber Cancer Institute

  Summary Available

Molecular Targets In Pediatric Malignancies

November 4–7, 2004

Chaired by:
 Gary Gilliland, MD, PhD of Howard Hughes Medical Institute
 Charles Sawyers, MD of UCLA

  Summary Available

Fertility And Reproductive Issues In Survivors Of Childhood Cancer

September 30–October 3, 2004

Chaired by:
 Charles Sklar, MD of Memorial Sloan Kettering Cancer Center

  Summary Available

DNA Damage & Cancer Susceptibility Syndromes

November 6–9, 2003

Chaired by:
 Alan D'andrea, MD of Dana-Farber Cancer Research Institute
 Jan Hoeijmakers of Erasmus University

  Summary Available

The New Biology of Enigmatic Neuroblastoma and Relevant Treatment Strategies

March 22–23, 2003

Chaired by:
 Moritz M. Zeigler, MD of Boston Children’s Hospital

  Summary Available

Cellular Senescence and Cancer

December 1, 2002

Chaired by:
 Ronald DePinho, MD of Harvard Medical School
 Charles Sherr, MD, PhD of St Jude Children’s Research Hospital

  Summary Available

A New Tool In Cancer Medicine: Exploiting The Patient’s Immunological Memory

April 19–21, 2002

Chaired by:
 Philipp Beckhove of German Cancer Research Center
 Volker Schirrmacher of German Cancer Research Center

  Summary Available

Differentiation as Cancer Therapy

December 1, 2001

Chaired by:
 Raymond Paul Warrell, Jr., MD of Genta Incorporated

  Summary Available

Mechanisms, Consequences, and Therapeutic Implications of Blood Vessel Leakiness in Cancer

October 4–7, 2001

Chaired by:
 Donald M. McDonald, PhD of University of California San Francisco

  Summary Available

Allogeneic Stem Cell Transplantation

November 1, 2000

Chaired by:
 Frederick R. Applebaum, MD of Fred Hutchinson Cancer Center

  Summary Available

Proteases as Cancer Therapeutic Targets

January 23–26, 2000

Chaired by:
 Lynn M. Matrisian, PhD of Vanderbilt University School of Medicine

  Summary Available

Targeting Gene Therapy - A Reality?

November 4–11, 1999

Chaired by:
 John D. Minna, MD of UT Southwestern
 Inder Verma, PhD of Salk Institute

  Summary Available

Infant Leukemia

June 3–6, 1999

Chaired by:
 John Kersey, MD
 Norma Ramsay, MD
 Leslie L. Robinson, PhD

  No Summary Available

Dendritic Cell Approaches to Immunotherapy

April 1–7, 1999

Chaired by:
 Bruce A. Chabner, MD of National Cancer Institute

  No Summary Available

Tumor Invasion and Metastasis

February 4–7, 1999

Chaired by:
 Arnold I. Freeman, MD of Hadassah University
 Israel Vlodavsky of Tumor Biology Research Institute

  Summary Available

Angiogenesis and Accessibility

November 5–8, 1998

Chaired by:
 Judah Folkman, MD of Harvard Medical School
 Rakesh K. Jain, PhD of Harvard Medical School

  Summary Available

Second Malignancies

November 6–9, 1997

Chaired by:
 Carlo M. Croce, MD of Jefferson Cancer Center

  Summary Available

Specific Simple Models to Clinical Disease

November 7–10, 1996

Chaired by:
 Richard Klausner, MD of National Cancer Institute

  Summary Available

Apoptosis

November 2–5, 1995

Chaired by:
 John T. Isaacs, PhD of Johns Hopkins University

  Summary Available

Cell Cycle Checkpoints

November 3–6, 1994

Chaired by:
 Leland Hartwell, PhD of University Of Washington

  Summary Available

Growth Factors

November 4–7, 1993

Chaired by:
 John Mendelsohn, MD of Memorial Sloan Kettering Cancer Center

  Summary Available

Gene Therapy & Tumor Vaccines

November 5–8, 1992

Chaired by:
 Drew Pardoll, MD, PhD of Johns Hopkins University

  Summary Available

Dose Intensification in Pediatric Embryonal Malignancies

November 7–10, 1991

Chaired by:
 Bruce Chabner, MD of National Cancer Institute

  Summary Available

Molecular Origins Of Pediatric Embryonal Malignancies

November 1–4, 1990

Chaired by:
 Mark A. Israel, MD of University Of California, San Francisco

  Summary Available

Infectious Complications

November 2–5, 1989

Chaired by:
 Philip A Pizzo, MD of National Cancer Institute

  Summary Available

Improved Drug Delivery To Brain Tumors

November 3–6, 1988

Chaired by:
 Arnold I. Freeman, MD of University Of Missouri

  Summary Available

Reasons For Drug Failure

November 5–8, 1987

Chaired by:
 Bruce Chabner, MD of National Cancer Institute

  Summary Available

Tumor Progression & Differentiation

November 6–9, 1986

Chaired by:
 Isaiah J. Fidler, DVM, PhD of MD Anderson Hospital

  Summary Available

Neuroblastoma

November 7–10, 1985

Chaired by:
 Arnold I. Freeman, MD of Roswell Park Memorial Institute

  Summary Available